The week in health tech, explained in plain English.Get the free newsletter →
October 4, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Payers

Why Health Plans Keep Losing on Out-of-Network Claims

Out-of-network claims are quietly draining health plans, and the arbitration process meant to settle them is tilted against payers. According to Healthcare Dive, roughly 88% of disputes that reach the federal Independent Dispute Resolution (IDR) process under the No Surprises Act are decided in favor of providers. When a claim lands in IDR, the plan usually loses and ends up paying more than it expected.

The volume of IDR cases has far exceeded what regulators anticipated when the No Surprises Act took effect, straining a system that was supposed to be a last resort. Every dispute also carries administrative cost and arbitration fees on top of the eventual payout, so escalation is expensive even before the ruling.

The practical takeaway for payers is to solve OON claims earlier. Accurate pricing, faster resolution, and better initial payment determinations keep claims out of arbitration entirely. Plans that treat IDR as the fix are optimizing the wrong end of the process.

More in Payers

Payers

7 Health System Insurers to Exit Medicare Advantage in 2027

Seven health system-owned insurers are among 11 health plans exiting the individual Medicare Advantage market in 2027, with several others narrowing to special needs plans only.

Why it matters: The exits signal that even provider-owned plans are struggling with Medicare Advantage economics, forcing seniors to find new coverage.

Payers

CMS Projects Lower MA Premiums, Flat Enrollment for 2027

CMS projects lower average Medicare Advantage premiums and flat enrollment of 34 million for 2027, a figure that already trails current membership of 36.1 million.

Why it matters: Medicare Advantage now covers nearly half of all Medicare enrollees, so its premium and growth trajectory shapes revenue for insurers, providers, and the federal budget.

Payers

PBMs Become Rare Bipartisan Target in Washington and States

A bipartisan push in Congress and statehouses aims to rein in pharmacy benefit managers, including proposals to force CVS and rivals to split their PBM and pharmacy businesses.

Why it matters: PBMs sit at the center of US drug pricing, and forced divestiture would upend the business models of the largest healthcare conglomerates.